SEATTLE — By now, even a quick look at drug companies' product pipelines and patient demographics should make it clear that specialty drugs are where it's at.
According to pharmacy benefit manager Express Scripts, the market for drugs used to treat complex, rare and serious conditions like cancer, HIV/AIDS, hepatitis C, autoimmune disorders and rare genetic diseases is set to grow by 67% by the end of 2015.